David Montez
2013
In 2013, David Montez earned a total compensation of $207.9K as Former Controller and Chief Accounting Officer at PDL BioPharma.
Compensation breakdown
| Non-Equity Incentive Plan | $57,942 |
|---|---|
| Salary | $105,000 |
| Stock Awards | $30,200 |
| Other | $14,720 |
| Total | $207,862 |
Montez received $105K in salary, accounting for 51% of the total pay in 2013.
Montez also received $57.9K in non-equity incentive plan, $30.2K in stock awards and $14.7K in other compensation.
Rankings
In 2013, David Montez's compensation ranked 11,549th out of 12,286 executives tracked by ExecPay. In other words, Montez earned more than 6.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,549 out of 12,286 | 6th |
Division Manufacturing | 4,337 out of 4,612 | 6th |
Major group Chemicals And Allied Products | 1,372 out of 1,462 | 6th |
Industry group Drugs | 1,090 out of 1,156 | 6th |
Industry Biological Products, Except Diagnostic Substances | 183 out of 196 | 7th |
Source: SEC filing on April 21, 2016.
Montez's colleagues
We found five more compensation records of executives who worked with David Montez at PDL BioPharma in 2013.
2013
John McLaughlin
PDL BioPharma
Chief Executive Officer
2013
Christopher Stone
PDL BioPharma
General Counsel
2013
Danny Hart
PDL BioPharma
Vice President, Business Development
2013
Peter Garcia
PDL BioPharma
Chief Financial Officer
2013
Caroline Krumel
PDL BioPharma